{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:30:49Z","timestamp":1770723049067,"version":"3.49.0"},"reference-count":10,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,1,28]]},"abstract":"<jats:p>A 48-year-old man presented to urgent care with recurrent epistaxis over 6\u2009months. Initially, nosebleeds were controlled with packing or cautery. Ultimately, he was referred to ear, nose and throat department and underwent nasal endoscopy which revealed polypoid tissue. A biopsy of the polyp showed non-specific inflammation with no evidence of malignancy. Follow-up maxillofacial CT revealed a large mass lesion in the right maxillary sinus, right nasal fossa, much of the ethmoids and right sphenoid, with destruction of adjacent bony structures. MRI revealed a mass in the right nasal cavity with extension into the ethmoid and anterior sphenoid sinus, anterior cranial fossa and medial orbits. Staging CT discovered metastatic disease in the adrenal glands and lymphadenopathy in the neck. The patient underwent endoscopic sinus surgery with debulking and tissue diagnosis of malignant melanoma. He completed radiation therapy to sinus and was subsequently enrolled in a clinical trial. Most recent imaging revealed complete metabolic response on positron emission tomography.<\/jats:p>","DOI":"10.1136\/bcr-2017-219832","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T10:35:27Z","timestamp":1518777327000},"page":"bcr-2017-219832","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Recurrent epistaxis leading to diagnosis of primary sinonasal melanoma"],"prefix":"10.1136","volume":"2018","clinical-trial-number":[{"clinical-trial-number":"nct02186249","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02186249","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02186249","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Karine","family":"Tawagi","sequence":"first","affiliation":[{"name":"Internal Medicine, Saint Joseph Mercy Ann Arbor Hospital, Ypsilanti, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Akaraz-Avedissian","sequence":"additional","affiliation":[{"name":"Internal Medicine, Saint Joseph Mercy Ann Arbor Hospital, Ypsilanti, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Burman-Solovyeva","sequence":"additional","affiliation":[{"name":"Internal Medicine, Saint Joseph Mercy Ann Arbor Hospital, Ypsilanti, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,2,16]]},"reference":[{"key":"2025082703200793000_2018.feb16_1.bcr-2017-219832.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.2005.03343.x"},{"key":"2025082703200793000_2018.feb16_1.bcr-2017-219832.2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0028-1115321","article-title":"Sinonasal mucosal melanoma: a 13-year experience at a single institution","volume":"19","author":"Narasimhan","year":"2009","journal-title":"Skull Base"},{"key":"2025082703200793000_2018.feb16_1.bcr-2017-219832.3","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199902000-00007"},{"key":"2025082703200793000_2018.feb16_1.bcr-2017-219832.4","unstructured":"ClinicalTrials.gov. Identifier NCT02186249, Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma (CheckMate218). 2017. Bethesda (MD): National Library of Medicine (US). 2014 July 8 \u2013 February 8, 2017. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02186249"},{"key":"2025082703200793000_2018.feb16_1.bcr-2017-219832.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.03.042"},{"key":"2025082703200793000_2018.feb16_1.bcr-2017-219832.6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24976"},{"key":"2025082703200793000_2018.feb16_1.bcr-2017-219832.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2008.01.014"},{"key":"2025082703200793000_2018.feb16_1.bcr-2017-219832.8","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21340"},{"key":"2025082703200793000_2018.feb16_1.bcr-2017-219832.9","doi-asserted-by":"publisher","DOI":"10.1002\/hed.2880130104"},{"key":"2025082703200793000_2018.feb16_1.bcr-2017-219832.10","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3892\/ol.2015.3259","article-title":"Clinical analysis of 29 cases of nasal mucosal malignant melanoma","volume":"10","author":"Yu","year":"2015","journal-title":"Oncol Lett"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-219832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:20:19Z","timestamp":1756290019000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-219832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,16]]},"references-count":10,"alternative-id":["10.1136\/bcr-2017-219832"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-219832","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,16]]}}}